Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04196530
Title BDB001-102 Open Label Dose Escalation Combination w Atezolizumab
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Birdie Biopharmaceuticals HK Limited
Indications

Advanced Solid Tumor

Therapies

Atezolizumab + BDB001

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.